Search
Erasca Inc
ERASAdd to Watchlist
13.670USD
-0.310-2.22%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
4.25BMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Frazier Life Sciences Management, L.P.
7.31%
Lim (Jonathan E)
6.26%
VR Adviser, LLC
5.74%
T. Rowe Price Investment Management, Inc.
5.18%
Paradigm BioCapital Advisors LP
4.87%
Other
70.64%
Shareholders
Shareholders
Proportion
Frazier Life Sciences Management, L.P.
7.31%
Lim (Jonathan E)
6.26%
VR Adviser, LLC
5.74%
T. Rowe Price Investment Management, Inc.
5.18%
Paradigm BioCapital Advisors LP
4.87%
Other
70.64%
Shareholder Types
Shareholders
Proportion
Investment Advisor
26.84%
Venture Capital
19.41%
Hedge Fund
15.49%
Private Equity
7.31%
Individual Investor
6.70%
Investment Advisor/Hedge Fund
6.57%
Corporation
3.96%
Research Firm
1.94%
Bank and Trust
0.24%
Other
11.56%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
333
240.06M
77.62%
-10.46M
2025Q4
302
232.29M
89.71%
--
2025Q3
310
232.29M
93.65%
-60.69K
2025Q2
313
232.41M
93.79%
-6.69M
2025Q1
306
239.26M
97.34%
-36.46M
2024Q4
312
245.09M
99.26%
-1.10M
2024Q3
302
246.05M
87.29%
+28.86M
2024Q2
292
216.94M
64.16%
+84.80M
2024Q1
269
85.99M
67.39%
-16.11M
2023Q4
259
82.61M
63.62%
+857.42K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Frazier Life Sciences Management, L.P.
22.73M
7.31%
--
--
Dec 31, 2025
Lim (Jonathan E)
19.46M
6.26%
--
--
Apr 15, 2025
VR Adviser, LLC
17.86M
5.75%
--
--
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
16.11M
5.18%
-4.12M
-20.37%
Dec 31, 2025
Paradigm BioCapital Advisors LP
15.16M
4.88%
+1.00M
+7.06%
Jan 07, 2026
Suvretta Capital Management, LLC
14.50M
4.67%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
13.50M
4.34%
+370.90K
+2.83%
Dec 31, 2025
Logos Global Management LP
13.00M
4.18%
-2.15M
-14.19%
Dec 31, 2025
City Hill Ventures, LLC
12.90M
4.15%
--
--
Sep 30, 2024
Novartis Pharma AG
12.31M
3.96%
--
--
Dec 31, 2024
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Virtus LifeSci Biotech Clinical Trials ETF
1.07%
ALPS Medical Breakthroughs ETF
0.28%
ProShares Ultra Nasdaq Biotechnology
0.11%
iShares Micro-Cap ETF
0.08%
Invesco Nasdaq Biotechnology ETF
0.07%
Fidelity Enhanced Small Cap ETF
0.05%
iShares Russell 2000 Value ETF
0.04%
iShares Biotechnology ETF
0.03%
ProShares UltraPro Russell2000
0.02%
iShares US Small-Cap Equity Factor ETF
0.02%
View more
Virtus LifeSci Biotech Clinical Trials ETF
Proportion1.07%
ALPS Medical Breakthroughs ETF
Proportion0.28%
ProShares Ultra Nasdaq Biotechnology
Proportion0.11%
iShares Micro-Cap ETF
Proportion0.08%
Invesco Nasdaq Biotechnology ETF
Proportion0.07%
Fidelity Enhanced Small Cap ETF
Proportion0.05%
iShares Russell 2000 Value ETF
Proportion0.04%
iShares Biotechnology ETF
Proportion0.03%
ProShares UltraPro Russell2000
Proportion0.02%
iShares US Small-Cap Equity Factor ETF
Proportion0.02%
